Compound information
- Natural Products
- NACP13757
- Molecular Formula
- C26H32O4
- Molecular Weight
- 408.230059504 g/mol
- Structure
-
- IUPAC Name
- 1-(4-hydroxy-3-methoxy-phenyl)-13-phenyl-tridec-1-ene-3,5-dione
- InChI
- InChI=1S/C26H32O4/c1-30-26-19-22(16-18-25(26)29)15-17-24(28)20-23(27)14-10-5-3-2-4-7-11-21-12-8-6-9-13-21/h6,8-9,12-13,15-19,29H,2-5,7,10-11,14,20H2,1H3
- InChI Key
- BXSFRFGPWVRRCH-UHFFFAOYSA-N
- SMILES
- O=C(C=CC1=CC=C(O)C(OC)=C1)CC(=O)CCCCCCCCC=2C=CC=CC2
- CAS
- SuperClass
- Phenylpropanoids and polyketides
- Class
- Cinnamic acids and derivatives
- SubClass
- Hydroxycinnamic acids and derivatives
- Source
- CNP0090967
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 2 |
Heteroatom Count | 4 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 63.6 Å2 | LogP | 5.51 |
LogS | -6.564 | LogD | 3.664 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.98 | Pgp substrate | 0.001 |
HIA | 0.97 | F20 % | 0.588 |
F30 % | 0.071 | Caco-2 | -4.732 |
MDCK | -4.571 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.999 | PPB | 75.984 |
VD | 0.726 | Fu | 2.032 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.857 | CYP1A2 substrate | 0.563 |
CYP2A6 substrate | 0.44 | CYP2B6 substrate | 0.614 |
CYP2C19 inhibitor | 0.809 | CYP2C19 substrate | 0.824 |
CYP2C8 substrate | 0.737 | CYP2C9 inhibitor | 0.673 |
CYP2C9 substrate | 0.008 | CYP2D6 inhibitor | 0.8 |
CYP2D6 substrate | 0.442 | CYP2E1 substrate | 0.273 |
CYP3A4 inhibitor | 0.788 | CYP3A4 substrate | 0.202 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.89 | CL | 7.208 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.38 | Hepatotoxicity | 0.329 |
Mutagenicity | 0.218 | Rat Oral Acute Toxicity | 0.48 |
FDAMDD | 0.643 | Skin Sensitization | 0.999 |
Carcinogenicity | 0.007 | Eye Corrosion | 0.0 |
Eye Irritation | 0.959 | Respiratory Toxicity | 0.645 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.933 | IGC50 | 5.922 |
LC50FM | 6.961 | LC50DM | 5.169 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.578 | NR-AR-LBD | 0.56 |
NR-AhR | 0.497 | NR-Aromatase | 0.465 |
NR-ER | 0.828 | NR-ER-LBD | 0.442 |
NR-PPAR-gamma | 0.893 | SR-ARE | 0.517 |
SR-ATAD5 | 0.723 | SR-HSE | 0.796 |
SR-MMP | 0.919 | SR-p53 | 0.61 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.